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Abstract
Epidermal Growth Factor Receptor (EGFR), a tyrosine kinase receptor, is one of the main
tumor markers in different types of cancers. The kinase native state is mainly composed of
two populations of conformers: active and inactive. Several sequence variations in EGFR
kinase region promote the differential enrichment of conformers with higher activity. Some
structural characteristics have been proposed to differentiate kinase conformations, but
these considerations could lead to ambiguous classifications. We present a structural char-
acterisation of EGFR kinase conformers, focused on active site pocket comparisons, and
the mapping of known pathological sequence variations. A structural based clustering of this
pocket accurately discriminates active from inactive, well-characterised conformations. Fur-
thermore, this main pocket contains, or is in close contact with,65% of cancer-related vari-
ation positions. Although the relevance of protein dynamics to explain biological function
has been extensively recognised, the usage of the ensemble of conformations in dynamic
equilibrium to represent the functional state of proteins and the importance of pockets, cavi-
ties and/or tunnels was often neglected in previous studies. These functional structures and
the equilibrium between them could be structurally analysed in wild type as well as in
sequence variants. Our results indicate that biologically important pockets, as well as their
shape and dynamics, are central to understanding protein function in wild-type, polymorphic
or disease-related variations.
Introduction
Conformational ensembles are nowadays increasingly used to understand protein function
[1]. However, most of those studies use backbone coordinates to define open and close con-
formers neglecting the importance of cavities, pockets and tunnels (gates of enzymes). In the
present work, pockets and cavities are considered to better characterise the alternative confor-
mations in the kinase region of the Epidermal Growth Factor Receptor (EGFR). This tyrosine
kinase receptor is one of the main tumor markers in many cancer types [2]. Its cytoplasmic
region is composed by a juxtamembrane (JM), a Tyr-kinase domain, and a C-terminal intrin-
sically disordered tail (C-tail) target of auto-phosphorylations which triggers signals involved
in different cell processes [3,4]. In different types of cancers, an increase in kinase activity and
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its resultant deregulation are observed [5,6]. Several single amino acid substitutions (SASs) as
well as insertions and deletions located in the kinase region and detected in patients affected
with different cancers, mainly non-small cell lung cancer (NSCLC), have been proposed as
cause of this kinase activity enhancement [7]. In the case of the EGFR kinase domain, as in
other kinases, the native state is mainly composed of two populations of conformers called
active and inactive or dormant structures [8,9]. Moreover, it has been proposed that the stabili-
sation of the EGFR kinase active conformation is mediated by the formation of an asymmetric
dimer (interface between the C-lobe of one subunit with the N-lobe of the other, Fig 1). Several
works have reported kinase activity assays and/or their corresponding structures, allowing the
generalisation of some structural and sequence features that are typical of active conformations
[10–13]. Unfortunately, some of these shared structural traits are, expectedly, not easily
detected in inactive conformations due to their intrinsic structural variability when compared
with their active counterparts. However, in the case of kinases, some inactive conformations
share common traits that have been repeatedly observed [14–16].
The identification of specific structural features of active and inactive conformations is rele-
vant to improve our understanding of the deregulation of enzyme activity, as well as to gain
knowledge on the specificity and selectivity of inhibitors [17,18]. This distinction is also
important to better evaluate the impact of sequence variants. Briefly, sequence variants may
cause active conformation enrichment at equilibrium due to the structural stabilisation of the
active conformation [19]. Alternatively, sequence variants may also have a destabilising effect
on inactive conformations, changing in both cases the ΔG barriers between conformers, with
the consequent enrichment of the active form at equilibrium [20,21]. Moreover, an alteration
of the inter-monomer interaction can also change enzyme activity due to equilibrium pertur-
bation. In the case of EGFR, the study on the effects of many reported sequence variants has
promoted a lot of research work in response to targeted therapy treatment decisions [22,23].
Phenotypic and clinical outcomes of several activating variants are well-known, but new ones
are frequently reported as a consequence of the currently progressive extension of the sequenc-
ing of patient samples [24,25]. Thus, when it is not possible to perform an activity assay, the
characterisation and eventual classification of each new sequence alteration using just
sequence, structural and evolutionary information is of great interest [26]. These analyses
could also, for each case, delimit the group of most appropriate inhibitors [17]. Thus, a struc-
tural description based on experimental data or derived from homology modelling, in silico
structural analysis or docking studies may improve our understanding of the structural and/or
functional effect of different reported variants [27–29].
In addition to the effect on kinase activity due to the enrichment of active conformer in the
equilibrium caused by a sequence variation, small molecule kinase inhibitors show different
conformer dependent mechanisms of binding. Thus, inhibitors of type I bind to active confor-
mations, while Types I½ and II to inactive ones. Several non-covalent inhibitors interact with
the kinase ATP-binding pocket, a structure with different characteristics depending on the
conformer type while others are bivalent or are allosteric [30,31], and protein allosterism also
depends on the conformational ensemble of the protein [32]. The selectivity and specificity of
these inhibitors also depend on the kinase sequence, structural or conformational differences
being a challenge in the recognition of the specific characteristics of each particular kinase [33–
35]. Briefly, and to bring the present work into focus, several distinctive characteristics of active
and inactive conformations are presented, following, in all descriptions, human EGFR canonical
amino acid sequence numbering (Universal Protein Resource, UniProtKB accession P00533,
isoform 1, 1210 amino acids in length). Two main structural elements are usually analysed to
distinguish between active and inactive kinase typical conformations. Firstly, the αC helix (posi-
tions 753–767, N-lobe) orientation: rotated inward against the N-lobe and towards the active
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site, this is characteristically observed in active conformers, and is crucial for kinase activity.
This αC helix disposition shorts the distance between E762 and K745, allowing a stabilising
ion–ion interaction (salt-bridge) between E762 of the αC helix and K745 in the β3 strand (740–
747, N-lobe; a detailed description is found in Jura et al. 2011 and the references therein [10])
which interact with the α and β phosphates of ATP to anchor and orient the ATP. Secondly, in
the activation segment (855–884), the Asp-Phe-Gly (DFG) motif at the beginning exhibits its
aspartate in an active state conformation pointing into the ATP-binding site and coordinating a
Mg+2 ion (only one per monomer can be observed so far, in all known crystal structures of
EGFR kinase). This organisation is accompanied by an open and extended conformation of the
activation loop, that is, a part of the activation segment, and is known as a DFG-in conforma-
tion. As a counterpart, several inactive kinase conformations show a DFG motif flipping
towards the orientation known as DGF-out, with an almost reciprocal change in the relative ori-
entation of D and F. In the out form, F is in the position previously occupied by aspartic acid.
The change in the αC helix towards the position known as the out state has been proposed, as a
general kinase activation mechanism, to be mediated by intermediate orientations, making the
Fig 1. EGFR kinase dimers and key structural elements important for catalysis and regulation. (A)
Superposition of A chains of a symmetric dimer (PDB 3GT8, in grey colours) and an asymmetric dimer (PDB
3IKA, in blue colours). Interfaces are depicted with dotted lines. (B) Active monomeric conformer with an ATP
analog+peptide conjugate (PDB 2GS6). Key structural elements are coloured magenta (Gly-rich loop), blue
(αC helix), violet (activation segment), green (catalytic loop), and sites in red (K745 in the AxK motif), orange
(T790 gatekeeper), yellow (catalytic spine residues) and cyan (regulatory spine residues). Ion pair (salt-
bridge) between K745 and E762 is depicted with a dashed green line. (C) Comparison of these elements in
active (PDB 2GS6) and inactive (PDB 3W32) monomers following the same colour scheme, but in lighter
tones. Main transitions of these elements from active to inactive are depicted with black arrows.
https://doi.org/10.1371/journal.pone.0189147.g001
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establishment of active or inactive αC helix orientation limits no easy task [11]. These elements
are shown in Fig 1b and 1c for two representative conformations of the EGFR kinase domain
(inactive PDB 3W32, active PDB 2GS6). Apart from these elements, there are others important
to the stabilisation of the ATP-active site interaction, also shared by different kinases, such as
the triad HRD (positions 835–837) in the catalytic loop [36]and different proposed amino acid
networks [37–40]. Of these networks, two are proposed to be involved in the regulation of
kinase activity: a catalytic spine (C-spine) and a regulatory spine (R-spine) [41].
Here, we examined the above described structural parameters in all human EGFR kinase
domains deposited in structural databases and previously characterised in bibliography as
active or inactive conformations. While several structures fulfilled all these structural criteria
and, consequently, were easily classified as active or inactive, others showed both active and
inactive features and, consequently, could not be unambiguously classified. Moreover, some
well-characterised structures with variants proposed for a long time to constitutively stabilise
the active conformation were, controversially, later reported as inactive [42]. At this point, con-
sidering the observed structural differences between conformers, in order to address some of
the previously reported controversies or ambiguous conformation classifications, and to recog-
nize the relevance of pockets, cavities and tunnels in protein function, we focused on their dif-
ferential features as observed in conformational comparisons. Pockets, cavities and tunnels are
structures that connect the protein surface with buried active or binding sites in proteins, and
that are essential for biological activity in most proteins [43]. Their conformational changes
define, for example, differential binding constants that may explain biological function, sub-
strate specificity and important regulatory processes such as allosterism [44,45]. A slight rota-
tion of certain given residues, usually called gatekeepers (e.g. bottleneck dynamics [46]) or
larger conformational changes (e.g. conformational gating [47] and malleability [48]) are the
main mechanisms controlling the transit of substrates and products to and from the protein
inside. The dynamic nature of the native state, at the expense of structural differences between
conformers, and their relation to changes in tunnels, pockets or cavities are essential for a com-
plete description of protein function. Their consideration could shed light in the sometimes
ambiguous conformer characterisation in proteins in general and in EGFR in particular.
In this work, a quantitative structural comparison of the pocket containing the active site
(main pocket) allowed the correct discrimination of EGFR kinase conformations (active/inac-
tive) taking also into account atypical conformer grouping. This comparison was performed
using a hierarchical clustering based on the root mean square deviation (RMSD) of α-carbons
belonging to positions of this main pocket. Even though there are several works considering
pockets related to the kinase active site, quantitative structural-derived comparisons are pre-
sented here for the first time [49]. Interestingly, our findings indicate that 53 main pocket-
belonging positions hold structural conformer-specific information when compared with
non-pocket positions. Additionally, the mapping and characterisation of reported cancer-asso-
ciated variants were also studied resulting in a notorious proportion of all the 153 kinase posi-
tion–holding variants (101 [ 65%]) which belong or are in close contact with this main
pocket. Finally, it is interesting to highlight the importance of these main pocket–shared posi-
tions in reflecting their backbone spatial constraints to regulate protein function.
Materials and methods
Structural conformations and sequence variants
Three-dimensional coordinates of the EGFR kinase domain conformers were retrieved from
CoDNAS (http://www.codnas.com.ar/ [50]) and PDB (http://www.pdb.org [51]). Multimeric
crystals were split into individual chains, resulting in a total of 103 conformers with a crystal
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resolution less than or equal to 3.00 Å. Available structures not already published with crystal
oligomeric structures different from well-known EGFR dimeric forms or involved in hetero-
oligomers were also removed.
Missing atoms of lateral chains were completed with the complete_pdb routine of Modeller
[51,52]. Sequence variants of the EGFR kinase domain for all types of cancer were obtained
from COSMIC (Catalog of Somatic Mutations in Cancer, http://cancer.sanger.ac.uk/
cancergenome/projects/cosmic/ [7,53]), specifically from the targeted screen (curated) data set
(version 78, September 2016).
Pocket calculation, structural alignments and data set building
Pockets, cavities and tunnels predictions on active and inactive conformers were performed
using Fpocket program [54]. Pockets related to the active site of the kinase domain, the main
pocket, were manually selected by visual inspection of the active conformers PDB ids 1M14
(apo form) and 2GS6, and by considering all EGFR residues within a 5 Å radius from each
atom of the ATP analog substrate–peptide conjugate in 2GS6 [55]; in this way, the main pocket
of the active site was defined including 53 positions. Also, a neighborhood of close contact resi-
dues was delimited, considering residues with atoms within a 5 Å radius from each pocket
amino acid. The value of 5 Å as limit to define a contact was chosen as a reasonable balance of
the energetic contribution of each type of noncovalent interaction at a given distance between
interacting atoms or residues [56–60].
As the rest of the pockets, cavities and tunnels were not shared by all the conformations,
even within active or inactive groups, this study was centered on the main pocket. All versus
all pairwise α-carbon structural alignments of kinase regions of all retrieved structures with a
resolution equal or better than 3 Å and with the exclusions previously mentioned were per-
formed with MAMMOTH [61]. To reduce redundancy and to avoid conformer over-repre-
sentations, structures derived from the same work and with a global α-carbon RMSD equal or
less than 0.50 Å were removed. This value is close to the estimated crystallographic method
error [62]. The final set consisted of 58 structures. Also, all versus all pairwise structural align-
ments were performed using the main pocket positions for each structure. In addition to this,
to study the biological information content of the 53 main pocket positions in the active-inac-
tive conformer division, 1000 resamplings were done, choosing randomly 53 non-pocket posi-
tions each time. For each sample, the 53 selected positions were pairwise α-carbon structurally
aligned, obtaining 1000 all vs. all RMSD matrices.
RMSD-based clustering
In order to explore the biological information content of the main pocket, hierarchical cluster-
ings were performed over all vs. all α-carbon RMSD values obtained taking into consideration
pocket and kinase positions. Neighbor–Joining and UPGMA clustering methods taken from
the Phylip package were used (Phylogeny Inference Package, version 3.7 a) [63]. Also, to study
the contribution of the 53 main pocket positions to the active-inactive conformer division,
1000 α-carbon RMSD hierarchical clusterings were estimated. They were then used to find the
Majority Rule Extended (MRE) [63] and Majority Rule (MR) [64] consensus clustering (data
not shown) using also the Phylip package.
Sequence variants were extracted from COSMIC and CLINVAR
databases
A total of 17234 samples containing EGFR kinase sequence variants were extracted from COS-
MIC [65]. A comparison with Clinvar [66] information reported no differences. Of those,
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16117 corresponded to NSCLC samples. Sequence variants taken from COSMIC, included
153 positions involved in SASs (missense substitutions), 47 different kinds of deletions and 25
different kinds of insertions in the kinase region. A detailed description of these sequence vari-
ants is included in S2 Table. Sequence variants in the Juxtamembrane Segment and C-tail are
also included.
Mutations mapping, DFG orientation, salt-bridge distances
The visualisation of conformers and pockets, mutation mapping and DFG orientation analysis
were performed using PyMOL in the active, inactive, monomeric and dimeric conformers of
the kinase domain. K745–E762 distance measurements of the N–O ion pair were performed
with ad hoc scripts. Cut-off distances for the salt-bridge range were taken from the works of J.
Thornton and R. Nussinov [67–69].
Results
Functional structures in EGFR
As previously mentioned, active conformations have their own structural particularities and
several common features that can also be extracted from inactive conformations (Fig 1). The
pocket limited by the two lobes houses the active site and is central in our comparisons. It is
evident at a glance, as well as from structural alignments, that some active and inactive confor-
mations are different; however, not all conformations are easily distinguished as active or inac-
tive. Specific examples of conformations that exhibit several structural traits of classical active
conformations and others that show inactive conformations are described in the next section.
Moreover, several specific characteristics appear in some groups. The established structural
parameters used to discriminate active from inactive kinase conformations were evaluated in
all available EGFR kinase structures, and are: DFG orientation, the distance between the N
atom of the epsilon amine group and K745 and the distance between the two oxygen atoms of
the gamma carboxyl group and E762. This analysis defines more than two conformer groups,
allowing different classification schemes. S1 Table includes the complete set of all available
experimental EGFR kinase structures, together with the current structural parameters used to
describe alternative conformations. Moreover, alternative orientations of DFG motive lateral
chains and distance range between K745–E762 were defined: three orientations for D and 6
for F lateral chains together with three intervals for ion–ion distances. S1 Fig shows these alter-
natives graphically. As seen in this figure, structural differences can be obtained by a structural
comparison of the backbone. The appearance of more than two conformer groups thus does
not allow a reliable differentiation of only one active and one inactive group. This impossibility
motivated us to search for an alternative structural criterion for comparisons aimed at discrim-
inating active from inactive conformations. Pocket comparisons were consequently
performed.
EGFR main pocket definition, alignment and clustering
The main pocket, which involves 53 positions, was defined using structural and biological
information, as described in Materials and Methods. Unlike other pockets, tunnels or cavities
detected in the kinase region of the EGFR, this main pocket is present and clearly distinguish-
able in all conformations. Because of that, the other pockets as well as different cavities and
sporadic or short tunnels were not considered. Additionally, positions involved in noncovalent
interactions with main pocket positions (contact positions) were registered (67). Main pocket
and contact positions are included in Fig 2, together with their corresponding exon number
Describing EGFR kinase conformations by pockets
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and the distinctive structural aspects of the region where they belong. Fig 3 includes a main
pocket structural comparison. Regarding main-pocket positions, an important proportion of
them have defined coordinates in all of the structures. Main pocket positions missing in at
least one conformer are: S719-F723 in Gly-rich loop, L858 and G873-V876 in the activation
segment. Both are flexible regions of the kinase domain; Gly-rich forms a cover on top of the
ATP and bridges to its γ-phosphate positioning it for the phosphoryl transfer.
The final data set with a resolution equal or better than 3 Å included 58 structures (selection
explained in the Materials and methods section). Fig 4 includes the Neighbor–Joining (N–J)-
based hierarchical clustering of α-carbon RMSD derived from the pairwise structural align-
ment of the positions belonging to the main pocket and, similarly S2 Fig shows the hierarchical
clustering of α-carbon RMSD of all kinase positions. The Unweighted Pair Group Method
with Arithmetic Mean (UPGMA)-based clusterings are very similar to N–J and are not shown.
As already mentioned, the previous classification of conformations as active or inactive was
taken from bibliography. The different colours reflect different groups of conformers, as
defined in S1 Table, according to their structural particularities.
Fig 2. Positions belonging to and in close contact with the main pocket. Exon: shows the limits of each
exon. Region: informs the conserved regions involved in catalytic control. Abbreviations: CS: catalytic spine;
ADi, SDi: assymetric/symmetric dimer interface; RS: regulatory spine; GK: gatekeeper. Position, list number
and residue for each position in the main pocket and close contact. P/C: depicts whether a position is
considered as part of the main pocket (P) or in close contact (C). Position and P/C rows are coloured,
according to the considerations in P/C, for those sites with defined coordinates in all the structures used in the
present work. Those in white correspond to positions that are found as missing in at least one of these
structures.
https://doi.org/10.1371/journal.pone.0189147.g002
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It is interesting to note that node A using pocket-based clustering mainly divides active
from inactive EGFR conformations. Alternatively, node B divides conformations leaving struc-
tures 5HG7, 5HG5 and 5HG8 grouped with the active ones. In order to explore the biological
information content of the main pocket positions, as explained in Materials and Methods, we
performed 1000 resamplings selecting at random 53 non-pocket positions that were later
structurally aligned and clustered. The1000 clusters that were obtained were used to find the
Majority Rule Extended (MRE) and Majority Rule (MR) consensus clustering (data not
shown). Node A shows a statistical support of 0.39 and node B of 0.21, even lower than node A
support. Moreover, these nodes are absent in Majority Rule (MR) Consensus clustering (data
not shown). These results highlight the biological information contained in main pocket posi-
tions in reference to their capacity to differentiate active from inactive conformations.
As it was previously mentioned, different groups of conformers have particular characteris-
tics, sharing structural features both with classical active or inactive conformations or having
their own particularities. For example, the group represented by the structures reported by
Cheng et al. [17], PDB ids 5HG7, 5HG5, 5HG8 and 5HG9, exhibit a classic DFG-out confor-
mation in the presence of ligands; however, their activation loop is in a state nearly identical to
the one in the active form. In pocket clustering groups, these conformers are separated from
the rest of the inactive group and also from the rest of the active conformations. Nevertheless,
in complete sequence clustering, they appear close to and share a node with three (uncom-
mon) inactive conformations, 3IKA_B, 3GOP_A and 3W2R_A, but do not share the orienta-
tion of the lateral chains of D845 and F846. 3IKA_B is the activator or donor chain in the
asymmetric dimer and it packs its C-lobe against the N-lobe of 3IKA_A. As it was already
mentioned, it has been proposed that the stabilisation of the EGFR kinase active conformation
is mediated by the formation of this asymmetric dimer [16]. However, unfortunately, 3IKA is
the only asymmetric dimer representant that we could include in RMSD clustering; because of
Fig 3. Main pocket comparison. Main pocket comparison between active (left, PDB 2GS6 with ATP analog–peptide conjugate)
and inactive (right, PDB 3W32 with pyrimido [4,5-b]azepine-derived inhibitor) monomers, following the same colouring scheme as
in Figs 1 and 2 (active: A colours, inactive: I colours). The 53 main pocket positions are represented as surfaces in both
monomers. For the symmetric and asymmetric interface residues, only those included or in close contact to the main pocket are
depicted in black and bright green, respectively.
https://doi.org/10.1371/journal.pone.0189147.g003
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Fig 4. Hierarchical clustering. Hierarchical clustering based on the α-carbon RMSD, using only main pocket
residues. Node A divides active and inactive conformations. Node B includes a particular group (PDBids:
5HG5:A; 5HG7:A; 5HG8:A) as part of active conformations’ group (see EGFR main pocket definition,
alignment and clustering section in Results).
https://doi.org/10.1371/journal.pone.0189147.g004
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lower resolutions, 2JIT, 2JIU, 4G5P and 4LL0 were discarded. This donor chains, also show
clear differences from all the other conformers when superposing their backbones (data not
shown). Unfortunately, even if these PDBs are the only ones showing this complete configura-
tion as asymmetric dimers in an asymmetric unit of a crystal, they all harbor the T790M varia-
tion. To explore the influence of these conformations in the native state in wild type as well as
in T790M and other possible variants, good resolution asymmetric wild type dimer crystals are
needed.
A significant number of disease-related EGFR kinase SASs belong to
the main pocket
A total of 17234 samples containing EGFR kinase sequence variants were extracted from COS-
MIC [65]; a comparison with Clinvar data [66] did not report changes. From these, 16117 cor-
respond to NSCLC samples. In terms of the different variations that are represented, sequence
variants taken from COSMIC include, in the kinase region, 153 positions involved in SASs
(single amino acid or missense substitutions), 47 different kinds of deletions and 25 different
kind of insertions. A detailed description of these sequence variants is included in S2 Table,
together with sequence variants located in the JM segment and C-tail. A notorious proportion
of all 15 kinase position-holding variants, 101 (65%), belong or are in close contact with the
main pocket. Thirty-six of the 101 correspond to main pocket positions for a total of 53 main
pocket positions (68% main pocket positions are involved in disease-associated sequence
variants) and 65 from 67 main pocket contact positions are also affected by variants (97%).
The calculation of this proportion for the remainder of the kinase positions (excluding the
main pocket and its contact positions) gives a percentage of44% (68 positions affected by
disease-associated variants over 153 kinase positions), showing a significant enrichment of the
main pocket and its contacts in positions affected by disease-related sequence variants. This
enrichment reflects the functional importance of both the main pocket and its contact posi-
tions, affecting protein activity both under normal physiological conditions as well as during
disease [70,71].
Discussion
The well-recognized importance of protein dynamics, the existence of an ensemble of confor-
mations in the native state of a protein [1], and changes in pockets’ structural features [43] to
improve our understanding of protein function make them essential aspects to take into
account in normal as well as in disease-related states. In terms of health care, for some well-
characterised pathologies at the molecular level, patient exon sequencing is, nowadays, con-
ducted much more frequently than in the past and provides very valuable, but not always con-
clusive, information. Increasing our knowledge on protein function underlying mechanisms
would certainly have an impact on our understanding of sequence variants effects on patients.
Although there are well-characterised sequence variants in terms of drug response in
EGFR, serious limitations in treatment decisions appear in some cases as a result of the incom-
plete characterisation of those previously unreported or with controversial classification. In
the present work, we studied the structures of previous experimentally determined EGFR
kinase domain structures, including the analysis of pockets and cavities. Moreover, all the can-
cer related sequence variants included in well-curated databases were structurally mapped in
different EGFR kinase domain conformations. We found that it is possible to discriminate pre-
viously reported conformations as active or inactive, as well as subsets with structural particu-
larities, by performing a main pocket structural comparison using α-carbon RMSD-based
hierarchical clusterings. Additionally,65% of kinase positions with reported variants in
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Fig 5. Variant site mapping over kinase domain conformers. The main pocket is represented as a surface. From left to right and from top to
bottom: active monomer with ATP analog–peptide conjugate (PDB id 2GS6), inactive monomer with pyrimido[4,5-b]azepine-derived inhibitor (PDB
id 3W32), active chain in asymmetric dimer with WZ4002 irreversible inhibitor (PDB id 3IKA_A), and inactive chain in asymmetric dimer (PDB id
3IKA_B). The most frequently affected sites (those in red, violet and dark blue) map in the catalytic pocket and are found in particular regions: the
activation segment (with the classical L858R), the Gly-rich loop, and the region that connects both lobes of the kinase. Interestingly, most of the
residues that serve as the docking site for the substrate peptide are not affected by variations (circled with a dashed black line). The total number of
Describing EGFR kinase conformations by pockets
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patients affected by cancer are in, or in close contact to, this main pocket. The enrichment in
disease-related variants of the main pocket position and its contacts compared to the rest of
the kinases reflects their functional importance and their putative effect on protein activity in
disease. Fig 5 includes a map of cancer-related variations in the EGFR kinase, reflecting how
these are enriched in the main pocket.
Previously established conformation classification criteria were sometimes not conclusive
due to the presence of intermediate positions, distances, orientations or angles [72]. It is also
interesting to note that hierarchical clusterings, taking into account all kinase or main pocket
positions, are similar but with some differences. However, the most significant finding of the
present work is that only 53 main pocket positions contain the structural information neces-
sary to discriminate active from inactive conformations, also allowing the grouping of atypical
conformations. This finding reflects both the biological meaning and the importance of pock-
ets in protein function and their relationship with reported disease-related sequence variants.
Thus, only 53 specific positions entail functional significant information, sustained by the low
support of nodes A and B as a result of the resampling analysis of 1000 replicates performed
after taking 53 positions at random over a total of220 kinase non-pocket positions. More-
over, of these 53 main pocket positions, an important fraction, 44 ( 83%), are structurally
defined in all conformers. This observation reflects, together with the fact that the main pocket
was the only recognizable one in all the conformers, the structural importance of these posi-
tions and their structural constraints. The information content rests, in addition, in backbone
coordinates.
It is noticeable that our results agree with the conclusions of previous works. Firstly, confor-
mations with a structural organisation that is intermediate between classically active or inac-
tive exist [17,73]. Secondly, several conformations with sequence variants, L858R and/or
T790M, belong to the inactive group according to the work of Gajiwala et al. [74]. In their
work, thermodynamic stability analysis of these structures supported their conclusions. These
sequence variants could be activating because of conformational equilibrium displacement not
being necessary to assume that the kinase adopts an active conformation (constitutively) to
explain their impact on kinase activity. A ligand’s presence, its concentration and the environ-
mental physicochemical conditions should also alter conformer populations, displacing the
equilibrium of alternative conformations of L858R and/or T790M variants which, by them-
selves, would not be able to significantly shift the conformational equilibrium towards active
forms.
Even though several groups have studied pockets related to the kinase active site, this work
presents, for the first time, quantitative calculations using main pocket structural comparisons
to allow a better discrimination of conformations. This work extends the quantitative study of
conformers with different activities. Moreover, this analysis may help to better structurally
characterise and, consequently, distinguish different sequence variants which could impact on
decisions related to patient treatment and the design and selection of inhibitors for disease.
Supporting information
S1 Fig. Alternative orientations of lateral chains of DFG residues. Backbones are coloured
according to the groups defined by F856 orientations (see S1 Table, column “dFg”). (A)
D855 in—D855 out. (Dfg). Superposition of backbones of DFG motif and catalytic loop. Mg2
+ ions correspond to the ones observed in inactive chains from symmetric dimers (PDB ids
missense substitutions observed in COSMIC for each position is listed in S2 Table, column Gen_var_count_ocurrence. Missing regions are
connected with straight dashed lines.
https://doi.org/10.1371/journal.pone.0189147.g005
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3GT8 and 2GS7, as orange and yellow balls respectively) and active chains in asymmetric het-
ero-dimers (PDB ids 4RIX, 4RIY, 4RIW, as green balls). (B) Different D855 orientations
(Dfg). IN, pointing to Mg2+ in active site. OUT and UP, two different orientations pointing
away from the active site. (C) Alternative F856 positions (dFg). Numbers 0 to 5 represent the
different categories used to divide conformations (a more detailed description is included in
S1 Table). (D) G857 positions (dfG).
(TIF)
S2 Fig. Hierarchical clustering based on the RMSD, including complete kinase residues.
(TIF)
S1 Table. Complete set of all available experimental EGFR kinase structures and structural
characterization.
(XLS)
S2 Table. COSMIC reported variants and structural related information. (A) Non-synony-
mous missense substitutions. (B) Deletions. (C) Insertions.
(XLS)
Acknowledgments
The authors would like to thank all members of the Structural Bioinformatics Group at Uni-
versidad Nacional de Quilmes (UNQ) for discussions and support. Also thanks Paula Bene-
ncio for manuscript proofreading.
Author Contributions
Conceptualization: Marcia Anahi Hasenahuer, Gustavo Parisi.
Data curation: Marcia Anahi Hasenahuer, German Patricio Barletta, Marı´a Silvina Fornasari.
Formal analysis: Marcia Anahi Hasenahuer, Gustavo Parisi, Marı´a Silvina Fornasari.
Funding acquisition: Gustavo Parisi.
Investigation: Marcia Anahi Hasenahuer, Gustavo Parisi, Marı´a Silvina Fornasari.
Methodology: Marcia Anahi Hasenahuer, Gustavo Parisi, Marı´a Silvina Fornasari.
Project administration: Gustavo Parisi.
Resources: Marcia Anahi Hasenahuer, Marı´a Silvina Fornasari.
Software: Marcia Anahi Hasenahuer, Marı´a Silvina Fornasari.
Supervision: Gustavo Parisi, Marı´a Silvina Fornasari.
Validation: Marcia Anahi Hasenahuer, Marı´a Silvina Fornasari.
Visualization: Marcia Anahi Hasenahuer.
Writing – original draft: Marcia Anahi Hasenahuer, Gustavo Parisi, Marı´a Silvina Fornasari.
Writing – review & editing: Marcia Anahi Hasenahuer, German Patricio Barletta, Sebastia´n
Fernandez-Alberti, Gustavo Parisi, Marı´a Silvina Fornasari.
Describing EGFR kinase conformations by pockets
PLOS ONE | https://doi.org/10.1371/journal.pone.0189147 December 11, 2017 13 / 17
References
1. Wei G, Xi W, Nussinov R, Ma B. Protein Ensembles: How Does Nature Harness Thermodynamic Fluc-
tuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell. Chem Rev.
2016; acs.chemrev.5b00562.
2. Henry NL, Lynn Henry N, Hayes DF. Cancer biomarkers. Mol Oncol. 2012; 6: 140–146. https://doi.org/
10.1016/j.molonc.2012.01.010 PMID: 22356776
3. Schlessinger J. Cell Signaling by Receptor Tyrosine Kinases. Cell. 2000; 103: 211–225. PMID:
11057895
4. Lemmon MA, Schlessinger J. Cell Signaling by Receptor Tyrosine Kinases. Cell. 2010; 141: 1117–
1134. https://doi.org/10.1016/j.cell.2010.06.011 PMID: 20602996
5. Arteaga CL, Engelman JA. ERBB receptors: from oncogene discovery to basic science to mechanism-
based cancer therapeutics. Cancer Cell. 2014; 25: 282–303. https://doi.org/10.1016/j.ccr.2014.02.025
PMID: 24651011
6. Kalia M, Madhu K. Biomarkers for personalized oncology: recent advances and future challenges.
Metabolism. 2015; 64: S16–S21. https://doi.org/10.1016/j.metabol.2014.10.027 PMID: 25468140
7. Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, et al. COSMIC: exploring the
world’s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015; 43: D805–11.
https://doi.org/10.1093/nar/gku1075 PMID: 25355519
8. Ferguson KM. Active and inactive conformations of the epidermal growth factor receptor. Biochem Soc
Trans. 2004; 32: 742–745. https://doi.org/10.1042/BST0320742 PMID: 15494003
9. Kornev AP, Taylor SS. Defining the conserved internal architecture of a protein kinase. Biochim Biophys
Acta. 2010; 1804: 440–444. https://doi.org/10.1016/j.bbapap.2009.10.017 PMID: 19879387
10. Jura N, Zhang X, Endres NF, Seeliger MA, Schindler T, Kuriyan J. Catalytic control in the EGF receptor
and its connection to general kinase regulatory mechanisms. Mol Cell. 2011; 42: 9–22. https://doi.org/
10.1016/j.molcel.2011.03.004 PMID: 21474065
11. Kornev AP, Haste NM, Taylor SS, Eyck LFT. Surface comparison of active and inactive protein kinases
identifies a conserved activation mechanism. Proc Natl Acad Sci U S A. 2006; 103: 17783–17788.
https://doi.org/10.1073/pnas.0607656103 PMID: 17095602
12. Valley CC, Arndt-Jovin DJ, Karedla N, Steinkamp MP, Chizhik AI, Hlavacek WS, et al. Enhanced dimer-
ization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancer. Mol
Biol Cell. 2015; 26: 4087–4099. https://doi.org/10.1091/mbc.E15-05-0269 PMID: 26337388
13. Kancha RK, Peschel C, Duyster J. The epidermal growth factor receptor-L861Q mutation increases
kinase activity without leading to enhanced sensitivity toward epidermal growth factor receptor kinase
inhibitors. J Thorac Oncol. 2011; 6: 387–392. https://doi.org/10.1097/JTO.0b013e3182021f3e PMID:
21252719
14. Shan Y, Arkhipov A, Kim ET, Pan AC, Shaw DE. Transitions to catalytically inactive conformations in
EGFR kinase. Proc Natl Acad Sci U S A. 2013; 110: 7270–7275. https://doi.org/10.1073/pnas.
1220843110 PMID: 23576739
15. Huse M, Morgan H, John K. The Conformational Plasticity of Protein Kinases. Cell. 2002; 109: 275–
282. PMID: 12015977
16. Zhang X, Xuewu Z, Jodi G, Kui S, Cole PA, John K. An Allosteric Mechanism for Activation of the Kinase
Domain of Epidermal Growth Factor Receptor. Cell. 2006; 125: 1137–1149. https://doi.org/10.1016/j.
cell.2006.05.013 PMID: 16777603
17. Cheng H, Hengmiao C, Nair SK, Murray BW, Chau A, Simon B, et al. Discovery of 1-(3R,4R)-3-[(5-
Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)methyl]-4-methoxypyr-
rolidin-1-ylprop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Con-
taining EGFR Mutants. J Med Chem. 2016; 59: 2005–2024. https://doi.org/10.1021/acs.jmedchem.
5b01633 PMID: 26756222
18. Kumar A, Petri ET, Halmos B, Boggon TJ. Structure and Clinical Relevance of the Epidermal Growth
Factor Receptor in Human Cancer. J Clin Oncol. 2008; 26: 1742–1751. https://doi.org/10.1200/JCO.
2007.12.1178 PMID: 18375904
19. Yun C-H, Boggon TJ, Li Y, Woo MS, Greulich H, Meyerson M, et al. Structures of lung cancer-derived
EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor
sensitivity. Cancer Cell. 2007; 11: 217–227. https://doi.org/10.1016/j.ccr.2006.12.017 PMID: 17349580
20. Kumar S, Ma B, Tsai CJ, Sinha N, Nussinov R. Folding and binding cascades: dynamic landscapes and
population shifts. Protein Sci. 2000; 9: 10–19. https://doi.org/10.1110/ps.9.1.10 PMID: 10739242
Describing EGFR kinase conformations by pockets
PLOS ONE | https://doi.org/10.1371/journal.pone.0189147 December 11, 2017 14 / 17
21. James LC, Tawfik DS. Conformational diversity and protein evolution–a 60-year-old hypothesis revis-
ited. Trends Biochem Sci. 2003; 28: 361–368. https://doi.org/10.1016/S0968-0004(03)00135-X PMID:
12878003
22. Zhang Z, Zhenfeng Z, Stiegler AL, Boggon TJ, Susumu K, Balazs H. EGFR-mutated lung cancer: a par-
adigm of molecular oncology. Oncotarget. 2010; 1: 497–514. https://doi.org/10.18632/oncotarget.186
PMID: 21165163
23. Russo A, Franchina T, Ricciardi GRR, Picone A, Ferraro G, Zanghı` M, et al. A decade of EGFR inhibi-
tion in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives.
Oncotarget. 2015; 6: 26814–26825. https://doi.org/10.18632/oncotarget.4254 PMID: 26308162
24. Forbes SA, Dave B, Prasad G, Kenric L, Charambulos B, Minjie D, et al. Abstract 62: COSMIC: Com-
bining the world’s knowledge of somatic mutation in human cancer. Cancer Res. 2015; 75: 62–62.
25. Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, et al. Molecular testing guide-
line for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the
College of American Pathologists, International Association for the Study of Lung Cancer, and Associa-
tion for Molecular Pathology. Arch Pathol Lab Med. 2013; 137: 828–860. https://doi.org/10.5858/arpa.
2012-0720-OA PMID: 23551194
26. Marks DS, Hopf TA, Sander C. Protein structure prediction from sequence variation. Nat Biotechnol.
2012; 30: 1072–1080. https://doi.org/10.1038/nbt.2419 PMID: 23138306
27. Tramontano A, Anna T. The role of molecular modelling in biomedical research. FEBS Lett. 2006; 580:
2928–2934. https://doi.org/10.1016/j.febslet.2006.04.011 PMID: 16647064
28. Dixit A, Verkhivker GM. Structure-functional prediction and analysis of cancer mutation effects in protein
kinases. Comput Math Methods Med. 2014; 2014: 653487. https://doi.org/10.1155/2014/653487 PMID:
24817905
29. Hasenahuer MA, Gustavo P, Marien G, Alberto L, Bramuglia GF, Fornasari MS. Twenty-One Novel
EGFR Kinase Domain variants in Patients with Nonsmall Cell Lung Cancer. Ann Hum Genet. 2015; 79:
385–393. https://doi.org/10.1111/ahg.12127 PMID: 26420346
30. Roskoski R Jr. Classification of small molecule protein kinase inhibitors based upon the structures of
their drug-enzyme complexes. Pharmacol Res. 2016; 103: 26–48. https://doi.org/10.1016/j.phrs.2015.
10.021 PMID: 26529477
31. Wang Q, Zorn JA, Kuriyan J. A structural atlas of kinases inhibited by clinically approved drugs. Meth-
ods Enzymol. 2014; 548: 23–67. https://doi.org/10.1016/B978-0-12-397918-6.00002-1 PMID:
25399641
32. Tsai C-J, Nussinov R. A unified view of “how allostery works.” PLoS Comput Biol. 2014; 10: e1003394.
https://doi.org/10.1371/journal.pcbi.1003394 PMID: 24516370
33. Mu¨ller S, Chaikuad A, Gray NS, Knapp S. The ins and outs of selective kinase inhibitor development.
Nat Chem Biol. 2015; 11: 818–821. https://doi.org/10.1038/nchembio.1938 PMID: 26485069
34. Fabbro D. 25 years of small molecular weight kinase inhibitors: potentials and limitations. Mol Pharma-
col. 2015; 87: 766–775. https://doi.org/10.1124/mol.114.095489 PMID: 25549667
35. Vijayan RSK, He P, Modi V, Duong-Ly KC, Ma H, Peterson JR, et al. Conformational analysis of the
DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors. J Med Chem.
2015; 58: 466–479. https://doi.org/10.1021/jm501603h PMID: 25478866
36. Knighton DR, Zheng JH, Ten Eyck LF, Ashford VA, Xuong NH, Taylor SS, et al. Crystal structure of the
catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science. 1991; 253:
407–414. PMID: 1862342
37. Hemmer W, McGlone M, Tsigelny I, Taylor SS. Role of the glycine triad in the ATP-binding site of
cAMP-dependent protein kinase. J Biol Chem. 1997; 272: 16946–16954. PMID: 9202006
38. Taylor SS, Kornev AP. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci.
2011; 36: 65–77. https://doi.org/10.1016/j.tibs.2010.09.006 PMID: 20971646
39. James KA, Verkhivker GM. Structure-based network analysis of activation mechanisms in the ErbB
family of receptor tyrosine kinases: the regulatory spine residues are global mediators of structural sta-
bility and allosteric interactions. PLoS One. 2014; 9: e113488. https://doi.org/10.1371/journal.pone.
0113488 PMID: 25427151
40. Hu J, Ahuja LG, Meharena HS, Kannan N, Kornev AP, Taylor SS, et al. Kinase regulation by hydropho-
bic spine assembly in cancer. Mol Cell Biol. 2015; 35: 264–276. https://doi.org/10.1128/MCB.00943-14
PMID: 25348715
41. Ten Eyck LF, Taylor SS, Kornev AP. Conserved spatial patterns across the protein kinase family. Bio-
chim Biophys Acta. 2008; 1784: 238–243. https://doi.org/10.1016/j.bbapap.2007.11.002 PMID:
18067871
Describing EGFR kinase conformations by pockets
PLOS ONE | https://doi.org/10.1371/journal.pone.0189147 December 11, 2017 15 / 17
42. Gajiwala KS, Feng J, Ferre R, Ryan K, Brodsky O, Weinrich S, et al. Insights into the aberrant activity of
mutant EGFR kinase domain and drug recognition. Structure. 2013; 21: 209–219. https://doi.org/10.
1016/j.str.2012.11.014 PMID: 23273428
43. Gora A, Artur G, Jan B, Jiri D. Gates of Enzymes. Chem Rev. 2013; 113: 5871–5923. https://doi.org/10.
1021/cr300384w PMID: 23617803
44. Gunasekaran K, Ma B, Nussinov R. Is allostery an intrinsic property of all dynamic proteins? Proteins.
2004; 57: 433–443. https://doi.org/10.1002/prot.20232 PMID: 15382234
45. Pravda L, Luka´sˇ P, Karel B, Vařekova´ RS, David S, Pavel B, et al. Anatomy of enzyme channels. BMC
Bioinformatics. 2014; 15. https://doi.org/10.1186/s12859-014-0379-x PMID: 25403510
46. Chovancova E, Pavelka A, Benes P, Strnad O, Brezovsky J, Kozlikova B, et al. CAVER 3.0: a tool for
the analysis of transport pathways in dynamic protein structures. PLoS Comput Biol. 2012; 8:
e1002708. https://doi.org/10.1371/journal.pcbi.1002708 PMID: 23093919
47. Zhou H-X, Wlodek ST, McCammon JA. Conformation gating as a mechanism for enzyme specificity.
Proceedings of the National Academy of Sciences. 1998; 95: 9280–9283.
48. Ikura M, Ames JB. Genetic polymorphism and protein conformational plasticity in the calmodulin super-
family: two ways to promote multifunctionality. Proc Natl Acad Sci U S A. 2006; 103: 1159–1164. https://
doi.org/10.1073/pnas.0508640103 PMID: 16432210
49. Liu W, Ning J-F, Meng Q-W, Hu J, Zhao Y-B, Liu C, et al. Navigating into the binding pockets of the
HER family protein kinases: discovery of novel EGFR inhibitor as antitumor agent. Drug Des Devel
Ther. 2015; 9: 3837–3851. https://doi.org/10.2147/DDDT.S85357 PMID: 26229444
50. Monzon AM, Juritz E, Fornasari MS, Parisi G. CoDNaS: a database of conformational diversity in the
native state of proteins. Bioinformatics. 2013; 29: 2512–2514. https://doi.org/10.1093/bioinformatics/
btt405 PMID: 23846747
51. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank.
Nucleic Acids Res. 2000; 28: 235–242. PMID: 10592235
52. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;
234: 779–815. https://doi.org/10.1006/jmbi.1993.1626 PMID: 8254673
53. Forbes SA, Gurpreet T, Chai K, Mingming J, Sally B, Jennifer C, et al. An Introduction to COSMIC, the
Catalogue of Somatic Mutations in Cancer. NCI Nature Pathway Interaction Database. 2008; https://
doi.org/10.1038/pid.2008.3
54. Le Guilloux V, Peter S, Pierre T. Fpocket: An open source platform for ligand pocket detection. BMC
Bioinformatics. 2009; 10: 168. https://doi.org/10.1186/1471-2105-10-168 PMID: 19486540
55. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. Crystal Structure of the inactive EGFR kinase
domain in complex with AMP-PNP [Internet]. 2006. https://doi.org/10.2210/pdb2gs7/pdb
56. Verkhivker G, Appelt K, Freer ST, Villafranca JE. Empirical free energy calculations of ligand-protein
crystallographic complexes. I. Knowledge-based ligand-protein interaction potentials applied to the pre-
diction of human immunodeficiency virus 1 protease binding affinity. Protein Eng. 1995; 8: 677–691.
PMID: 8577696
57. Berrera M, Molinari H, Fogolari F. Amino acid empirical contact energy definitions for fold recognition in
the space of contact maps. BMC Bioinformatics. 2003; 4: 8. https://doi.org/10.1186/1471-2105-4-8
PMID: 12689348
58. Bickerton GR, Higueruelo AP, Blundell TL. Comprehensive, atomic-level characterization of structurally
characterized protein-protein interactions: the PICCOLO database. BMC Bioinformatics. 2011; 12: 313.
https://doi.org/10.1186/1471-2105-12-313 PMID: 21801404
59. Piovesan D, Minervini G, Tosatto SCE. The RING 2.0 web server for high quality residue interaction net-
works. Nucleic Acids Res. 2016; 44: W367–74. https://doi.org/10.1093/nar/gkw315 PMID: 27198219
60. Velec HFG, Gohlke H, Klebe G. DrugScore(CSD)-knowledge-based scoring function derived from
small molecule crystal data with superior recognition rate of near-native ligand poses and better affinity
prediction. J Med Chem. 2005; 48: 6296–6303. https://doi.org/10.1021/jm050436v PMID: 16190756
61. Lupyan D, Leo-Macias A, Ortiz AR. A new progressive-iterative algorithm for multiple structure align-
ment. Bioinformatics. 2005; 21: 3255–3263. https://doi.org/10.1093/bioinformatics/bti527 PMID:
15941743
62. Kuriyan J, Karplus M, Petsko GA. Estimation of uncertainties in X-ray refinement results by use of per-
turbed structures. Proteins. 1987; 2: 1–12. https://doi.org/10.1002/prot.340020102 PMID: 3447165
63. Baum BR. PHYLIP: Phylogeny Inference Package. Version 3.2 Joel Felsenstein. Q Rev Biol. 1989; 64:
539–541.
64. Margush T, McMorris FR. Consensusn-trees. Bull Math Biol. 1981; 43: 239–244.
Describing EGFR kinase conformations by pockets
PLOS ONE | https://doi.org/10.1371/journal.pone.0189147 December 11, 2017 16 / 17
65. Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, et al. COSMIC: exploring the
world’s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015; 43: D805–11.
https://doi.org/10.1093/nar/gku1075 PMID: 25355519
66. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of
relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014; 42: D980–5.
https://doi.org/10.1093/nar/gkt1113 PMID: 24234437
67. Kumar S, Nussinov R. Relationship between ion pair geometries and electrostatic strengths in proteins.
Biophys J. 2002; 83: 1595–1612. https://doi.org/10.1016/S0006-3495(02)73929-5 PMID: 12202384
68. Kumar S, Nussinov R. Salt bridge stability in monomeric proteins. J Mol Biol. 1999; 293: 1241–1255.
https://doi.org/10.1006/jmbi.1999.3218 PMID: 10547298
69. Barlow DJ, Thornton JM. Ion-pairs in proteins. J Mol Biol. 1983; 168: 867–885. PMID: 6887253
70. Chovancova E, Pavelka A, Benes P, Strnad O, Brezovsky J, Kozlikova B, et al. CAVER 3.0: a tool for
the analysis of transport pathways in dynamic protein structures. PLoS Comput Biol. 2012; 8:
e1002708. https://doi.org/10.1371/journal.pcbi.1002708 PMID: 23093919
71. Kingsley LJ, Lill MA. Substrate tunnels in enzymes: structure-function relationships and computational
methodology. Proteins. 2015; 83: 599–611. https://doi.org/10.1002/prot.24772 PMID: 25663659
72. Huse M, Morgan H, John K. The Conformational Plasticity of Protein Kinases. Cell. 2002; 109: 275–
282. PMID: 12015977
73. Vijayan RSK, He P, Modi V, Duong-Ly KC, Ma H, Peterson JR, et al. Conformational analysis of the
DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors. J Med Chem.
2015; 58: 466–479. https://doi.org/10.1021/jm501603h PMID: 25478866
74. Gajiwala KS, Feng J, Ferre R, Ryan K, Brodsky O, Weinrich S, et al. Insights into the aberrant activity of
mutant EGFR kinase domain and drug recognition. Structure. 2013; 21: 209–219. https://doi.org/10.
1016/j.str.2012.11.014 PMID: 23273428
Describing EGFR kinase conformations by pockets
PLOS ONE | https://doi.org/10.1371/journal.pone.0189147 December 11, 2017 17 / 17
